Mumbai : Inventurus Knowledge Solutions Limited is highlighting its initial public offering (IPO) of Equity Shares priced at between Rs 1,265 and Rs 1,329 – aggregating to Rs 2,498 crore – which will open on December 12, 2024 and close on December 16, 2024.
Inventurus Knowledge Solutions Limited is a technology-enabled healthcare solutions provider that offers a care enablement platform assisting physician enterprises in the US, Canada and Australia, with a focus on the US markets.
The Company offers a comprehensive platform to enable healthcare enterprises across outpatient and inpatient care, while also enabling healthcare organizations to deliver superior clinical care, improve population health outcomes, and transition to the “fee for value” model alongside optimizing their revenue and reducing operating costs.
Sachin Gupta, Whole-Time Director and Chief Executive Officer, Inventurus Knowledge Solutions Limited) told media at the IPO press conference here recently that the Company’s focus is on the U.S. healthcare industry, presently valued at $4.8 trillion and growing between 7%-8% annually due to population ageing or sick due to sedentary lifestyles.
With the U.S. economy at 20% GDP, the U.S. is spending more than any economy on healthcare even as macro changes are pushing its healthcare needs to continuous growth, he said, adding that patient experience is the differentiator, beside also the addition of technology-enabled globalised delivery layer to the care delivery pyramid.
Successful integration will enable the Company to capture synergies from both the technological and profitability initiatives, he said.
Replying to questions, he said “Ours is an organic growth story in making smart-tech relevant for our customers and AI is having a terrific impact on our business model. With 28% EBITDA margins, we have 50+ sales and marketing persons in the U.S. market.”
The Equity Shares of the Company are proposed to be listed on BSE Limited (“BSE“)and the National Stock Exchange of India Limited (“NSE”).
ICICI Securities Limited, Jefferies India Private Limited, JM Financial Limited, J.P. Morgan India Private Limited, and Nomura Financial Advisory and Securities (India) Private Limited are the Book Running Lead Managers to the issue.
